Virtus ETF Advisers’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,133
| Closed | -$67.6K | – | 561 |
|
|
2024
Q4 | $67.6K | Sell |
5,133
-2,564
| -33% | -$33.8K | 0.03% | 401 |
|
|
2024
Q3 | $86.3K | Buy |
7,697
+134
| +2% | +$1.5K | 0.04% | 399 |
|
|
2024
Q2 | $81.3K | Buy |
7,563
+2,396
| +46% | +$25.8K | 0.04% | 399 |
|
|
2024
Q1 | $77K | Sell |
5,167
-354
| -6% | -$5.28K | 0.04% | 397 |
|
|
2023
Q4 | $100K | Buy |
5,521
+1,455
| +36% | +$26.4K | 0.06% | 361 |
|
|
2023
Q3 | $70.5K | Sell |
4,066
-403
| -9% | -$6.99K | 0.04% | 384 |
|
|
2023
Q2 | $81K | Sell |
4,469
-810
| -15% | -$14.7K | 0.05% | 427 |
|
|
2023
Q1 | $140K | Sell |
5,279
-2,024
| -28% | -$53.8K | 0.08% | 320 |
|
|
2022
Q4 | $141K | Buy |
+7,303
| New | +$141K | 0.07% | 363 |
|
|
2022
Q2 | – | Sell |
-10,224
| Closed | -$72K | – | 465 |
|
|
2022
Q1 | $72K | Sell |
10,224
-603
| -6% | -$4.25K | 0.03% | 348 |
|
|
2021
Q4 | $146K | Buy |
10,827
+4,361
| +67% | +$58.8K | 0.06% | 356 |
|
|
2021
Q3 | $109K | Sell |
6,466
-333
| -5% | -$5.61K | 0.05% | 376 |
|
|
2021
Q2 | $198K | Sell |
6,799
-4,151
| -38% | -$121K | 0.08% | 352 |
|
|
2021
Q1 | $431K | Buy |
10,950
+191
| +2% | +$7.52K | 0.18% | 167 |
|
|
2020
Q4 | $244K | Buy |
+10,759
| New | +$244K | 0.1% | 319 |
|